Clinical Trial Update: A Study to Evaluate MWN109 Injection in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate MWN109 injection in healthy subjects with overweight or obesity. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• MWN109 Injection

Snippet

Sponsor: Shanghai Minwei Biotechnology Co., Ltd | Conditions: Overweight or Obese | Phase 1 | Status: RECRUITING